T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.
Schmid D, Park CG, Hartl CA, Subedi N, Cartwright AN, Puerto RB, Zheng Y, Maiarana J, Freeman GJ, Wucherpfennig KW, Irvine DJ, Goldberg MS.
Schmid D, et al. Among authors: subedi n.
Nat Commun. 2017 Nov 23;8(1):1747. doi: 10.1038/s41467-017-01830-8.
Nat Commun. 2017.
PMID: 29170511
Free PMC article.